This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Tabrix

Profile

TaBriX is a UK-based biotech startup company developing innovative therapies for difficult to treat & life-endangering infections in chronic patients. Our lead asset is a first-in-class, broad-spectrum, anti-virulent small molecule designed to be delivered orally, to treat non-tuberculous mycobacteria (NTMs) in patients with cystic fibrosis and bronchiectasis.